Navigation Links
Accuray Hires General Manager for Japan
Date:11/13/2009

SUNNYVALE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Juki Hozumi has joined Accuray as General Manager of Japan effective November 1, 2009.

Prior to joining Accuray, Hozumi worked for Johnson & Johnson where he served as Vice President of LifeScan, Japan and General Manager of Independence Technology. Prior to joining Johnson & Johnson, Hozumi held various business leadership positions in Sales & Marketing, Business Development, Corporate Planning, and Channel Development at GE Medical Systems and Apple Japan.

"Juki Hozumi's established track record in both larger global companies where he drove rapid growth and acceptance of new product offerings, and smaller companies where he built and lead teams to grow market share, is a perfect complement to Accuray Japan," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray Incorporated. "We are very excited to have him on board and see this as a major step toward the success of our regional business model and the CyberKnife System's global expansion."

Hozumi will report to Accuray's president and chief executive officer, Euan Thomson, and will be fully responsible for leading sales, service and marketing for the Japan region.

Presently there are 21 CyberKnife Systems installed throughout Japan, making it the second largest installed base of CyberKnife Systems after the United States.

About the CyberKnife® Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 70,000 patients worldwide and currently 180 Systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to qualitative management experience and commercialization of products are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2009 fiscal year, our Form 10-Q filed on November 6, 2009 and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

SOURCE Accuray Incorporated


'/>"/>
SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
2. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
3. Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500(TM)
4. Accuray Announces Regionalized Management Strategy for Americas
5. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
6. Accuray Introduces the CyberKnife(R) VSI(TM) System
7. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
8. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
9. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
10. CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
11. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 On Wednesday, February 22, ... four out of nine sectors finished the trading sessions in ... flat closing. Major US indices were also mixed at the ... at 5,860.63, slightly down by 0.09%; the Dow Jones Industrial ... S&P 500 closed at 2,362.82, down 0.11%. This Thursday morning, ...
(Date:2/23/2017)... MIAMI , February 23, 2017 ML ... stake in Colorado Highlife Tours , a ... strategic plan in partnership with Puration, Inc. (USOTC: PURA) to enter ... luxury cannabis tours product. The Colorado Highlife Tours acquisition announced today ... cannabis tourism strategy. ...
(Date:2/23/2017)... and VANCOUVER, British Columbia , Feb. ... OGXI ) today announced its year end 2016 financial ... In January 2017, OncoGenex, and Achieve Life Science, Inc., a ... entered into a definitive merger agreement under which OncoGenex ... of the proposed merger, Achieve,s stockholders are expected to ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy ... effective with the April 2017 testing period. NACCM, a nonprofit organization, has provided ... Certified (CMC) exam is periodically re-calibrated to ensure that newly certified professionals are ...
(Date:2/22/2017)... , ... February 22, 2017 ... ... solution leverages advanced data analytics to accurately understand each Medicare Advantage member’s ... for a given population. This new solution helps transform the HCC Risk ...
(Date:2/22/2017)... ... ... Doctors on Liens is continuing its steady expansion of medical specialties throughout ... North Valley Eye Medical Group in Mission Hills . Eye injuries and vision ... cases. These injuries have a major impact on the quality of life of ...
(Date:2/22/2017)... ... ... Using the power of the internet, IdrisArkette.com has managed to produce more than ... 24 months, thousands of individuals interested in a medical procedure managed to be rounded ... not getting quieter. In fact it’s becoming noisier by the day. If you don’t ...
(Date:2/22/2017)... Charleston, WV (PRWEB) , ... February 22, 2017 ... ... has awarded a contract to Quality Insights to help small practices in Delaware, ... Quality Payment Program, established by the Medicare Access and CHIP Reauthorization Act of ...
Breaking Medicine News(10 mins):